TPG Capital $135 million acquisition of Sai Life Sciences

30/7/2018
Private acquisition

Af 135 million

Announced

30/7/2018


Overview:

  • TPG Capital will acquire Tata Capital's 33% stake in Sai Life Sciences.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

India

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Sai Life Sciences Ltd (Target)


Party: TPG Capital (Acquirer)


Party: Tata Capital Ltd (Seller)